Cutaneous lupus erythematosus is associated with an increased risk for ASCVD, similar to the risk seen in association with SLE.

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Discover how air pollution impacts autoimmune diseases like rheumatoid arthritis and lupus, based on groundbreaking genetic ...

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in ...

Lupus itself is fairly rare ... That was a rude awakening to the severity of her disease. “That was a time for me to be like, ‘Oh, this stuff was actually really working,’” she said.

Halsey reflected on the past two years following a diagnosis with Lupus SLE and a rare T-cell lymphoproliferative disorder ...

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...